These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23911172)

  • 1. Higher accuracy of self-monitoring of blood glucose in insulin-treated patients in Germany: clinical and economical aspects.
    Schnell O; Erbach M; Wintergerst E
    J Diabetes Sci Technol; 2013 Jul; 7(4):904-12. PubMed ID: 23911172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a reduced error range of SMBG in insulin-treated patients in Germany.
    Schnell O; Erbach M
    J Diabetes Sci Technol; 2014 May; 8(3):479-82. PubMed ID: 24876609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of Metabolic Control and Diabetes Management in Insulin-Treated Patients Results in Substantial Cost Savings for the German Health System.
    Fritzen K; Gutschek B; Coucke B; Zakrzewska K; Hummel M; Schnell O
    J Diabetes Sci Technol; 2018 Sep; 12(5):1002-1006. PubMed ID: 29436251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management.
    Fritzen K; Basinska K; Rubio-Almanza M; Nicolucci A; Kennon B; Vergès B; Zakrzewska K; Schnell O
    J Diabetes Sci Technol; 2019 Nov; 13(6):1112-1122. PubMed ID: 30917691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems.
    Fritzen K; Basinska K; Stautner C; Braun KF; Rubio-Almanza M; Nicolucci A; Kennon B; Vergès B; Hosny Y; Schnell O
    J Diabetes Sci Technol; 2020 Mar; 14(2):262-270. PubMed ID: 31387385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of paediatric diabetes care in Germany: current situation and comparison with the year 2000.
    Bächle CC; Holl RW; Straßburger K; Molz E; Chernyak N; Beyer P; Schimmel U; Rütschle H; Seidel J; Lepler R; Holder M; Rosenbauer J; Icks A; ;
    Diabet Med; 2012 Oct; 29(10):1327-34. PubMed ID: 22417295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications and economic impact of accuracy differences among commercially available blood glucose monitoring systems.
    Budiman ES; Samant N; Resch A
    J Diabetes Sci Technol; 2013 Mar; 7(2):365-80. PubMed ID: 23566995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
    Willis WD; Diago-Cabezudo JI; Madec-Hily A; Aslam A
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):123-30. PubMed ID: 23402452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
    Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
    Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.
    Hellmund R; Weitgasser R; Blissett D
    Diabetes Res Clin Pract; 2018 Apr; 138():193-200. PubMed ID: 29410149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.
    Roze S; Saunders R; Brandt AS; de Portu S; Papo NL; Jendle J
    Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct costs of pediatric diabetes care in Germany and their predictors.
    Icks A; Rosenbauer J; Haastert B; Rathmann W; Grabert M; Gandjour A; Giani G; Holl RW
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):302-9. PubMed ID: 15216447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting health and reducing costs: a role for reform of self-monitoring of blood glucose provision within the National Health Service.
    Leigh S; Idris I; Collins B; Granby P; Noble M; Parker M
    Diabet Med; 2016 May; 33(5):681-90. PubMed ID: 26443548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study.
    Charleer S; De Block C; Van Huffel L; Broos B; Fieuws S; Nobels F; Mathieu C; Gillard P
    Diabetes Care; 2020 Feb; 43(2):389-397. PubMed ID: 31843948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197.
    Freckmann G; Baumstark A; Jendrike N; Zschornack E; Kocher S; Tshiananga J; Heister F; Haug C
    Diabetes Technol Ther; 2010 Mar; 12(3):221-31. PubMed ID: 20151773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Accuracy of 17 Point-of-Care Glucose Meters.
    Ekhlaspour L; Mondesir D; Lautsch N; Balliro C; Hillard M; Magyar K; Radocchia LG; Esmaeili A; Sinha M; Russell SJ
    J Diabetes Sci Technol; 2017 May; 11(3):558-566. PubMed ID: 27697848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.
    Tang F; Wang Y
    J Diabetes Sci Technol; 2017 Nov; 11(6):1112-1123. PubMed ID: 28728434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England.
    Perera R; Oliver N; Wilmot E; Marriott C
    Diabet Med; 2018 Nov; 35(11):1617-1618. PubMed ID: 29931731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.